EirGenix Inc. (TPE:6589)
Taiwan · Delayed Price · Currency is TWD 51.20
+2.25 (4.60%)
Sep 17, 2026, 1:30 PM CST
EirGenix Market Cap
EirGenix has a market cap or net worth of 15.29 billion as of September 17, 2026. Its market cap has decreased by -16.69% in one year.
Market Cap
15.29B
Enterprise Value
14.13B
Revenue
1.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
51.20
ChartMarket Cap Chart
Since November 23, 2016, EirGenix's market cap has increased from 4.56B to 15.29B, an increase of 235.51%. That is a compound annual growth rate of 13.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 15.29B | -18.10% |
| Dec 31, 2025 | 18.67B | -15.33% |
| Dec 31, 2024 | 22.05B | -28.29% |
| Dec 29, 2023 | 30.75B | -17.85% |
| Dec 30, 2022 | 37.43B | 11.81% |
| Dec 30, 2021 | 33.48B | 245.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunmax Biotechnology | 21.35B |
| Oneness Biotech | 21.19B |
| CHO Pharma | 21.19B |
| Medigen Vaccine Biologics | 19.89B |
| TaiMed Biologics | 16.28B |
| Ever Supreme Bio Technology | 15.87B |
| Gongwin Biopharm Holdings | 15.20B |
| ACRO Biomedical | 13.03B |